MedTrace Logo

Follow-up Assessment of a Trial of Open-label Placebos for Women With Premenstrual Syndrome

NCT06206460 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2024-08-16

No results posted yet for this study

Summary

With the proposed study, the investigators aim to evaluate the long-term efficacy of the open-label placebo (OLP) intervention in premenstrual syndrome (PMS) and to contribute to a broader understanding of how OLPs work. It is planned to survey participants of the intervention groups (OLP+ and OLP-) regarding symptom intensity and impairment due to PMS after the conclusion of our randomized controlled trial (RCT) and intervention provision. Additionally, it will be examined if there is a difference between the OLP group with and without a treatment rationale (OPL+ vs. OLP-) across time. More precisely, it will be investigated whether participants of the intervention groups with and without treatment rationale experience any long-term improvement.

Conditions

  • Premenstrual Syndrome

Interventions

OTHER

Online Assessment

Online Assessment which consists of: * Sociodemographic data (life changes, medical and gynaecological history) * German PMS symptom diary retrospectively for last menstrual cycle * Quality of Life Inventory (SF-12) * Expectancy of relief

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-04
Primary Completion
2024-07-03
Completion
2024-07-03

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06206460 on ClinicalTrials.gov